Ignite Creation Date:
2025-12-24 @ 5:02 PM
Ignite Modification Date:
2026-02-27 @ 2:19 PM
Study NCT ID:
NCT03924050
Status:
UNKNOWN
Last Update Posted:
2022-12-27
First Post:
2019-04-18
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Toripalimab Plus Pemetrexed+Platinus in Advanced Non-small-cell Lungcancer Patients Previsouly Treated EGFR-TKI
Sponsor:
Shanghai Junshi Bioscience Co., Ltd.
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
JS001-CT25-III-NSCLC
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None